Denali Therapeutics (NASDAQ: DNLI) Stock Analysis: Navigating Setbacks and Seizing Growth Opportunities
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameDenali Therapeutics Inc.
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









